The CTSC houses a number of databases which are available to HSC investigators. Each of these provides access to different kinds of patient data that can be mined for research.
Some of our databases contain de-identified data and can be explored by the investigator or members of the research team on a self-serve basis. These databases can help identify potential cohorts to determine study feasibility.
Access to identified patient data requires IRB approval, and usually requires coordination with a CTSC honest broker.
Requests for data or access to CTSC databases can be made through the CTSC Data Request Form.
HSC researchers may request data from the UNMH Electronic Health Record. Approved requests are assigned to a CTSC honest broker who extracts the data and releases it in accordance with all applicable approvals and regulations. All requests must be approved by the CTSC Data Request Review Committee and be associated with a protocol submitted to the HSC Human Research Protections Office.
Health Facts
HealthFacts contains de-identified electronic health record (EHR) data from over 600 participating Cerner client hospitals and clinics in the United States, representing over 106 million unique patients. With this longitudinal, relational database, UNM researchers can analyze detailed sets of de-identified clinical data at the patient level. Available data include demographics, encounters, diagnoses, procedures, lab results, medication orders, medication administration, vital signs, microbiology, surgical cases, other clinical observations, and health systems attributes. Currently available to all UNM HSC faculty.
i2b2
i2b2 (Informatics Integrating Biology & the Bedside) provides a self-service means of exploring de- identified data from UNM’s electronic medical record and from billing diagnoses. i2b2 will be available to investgators via local ACT netwok summer 2021.
IBM MarketScan
IBM MarketScan is the most recent database to be installed on CTSC servers. It contains complete information on inpatient prescriptions, as well as links to outpatient prescription data. MarketScan data also contain diagnoses which can be used to determine the influence of clinical, demographic, and provider characteristics upon prescribing patterns. Individual patients’ prescription fills are recorded so concurrently prescribed drugs can also be identified. MarketScan will be available to Investigators via ATLAS spring 2021.